E

ESLAW

Estrella Immunopharma

0.05

0.000.00%
Closed09:30 07/01 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
Total Assets

4.45M

3.03M

4.92M

45.80M

Total Current Assets

4.45M

2.75M

4.92M

616.03K

Total Non Current Assets

0

276.19K

0

45.19M

Total Liabilities

180.70K

9.77M

961.51K

1.62M

Total Current Liabilities

180.70K

9.76M

946.68K

73.15K

Total Non Current Liabilities

0

12.73K

14.83K

1.55M

Total Equity

4.27M

-6.74M

3.96M

44.18M

Total Stockholders Equity

4.27M

-6.74M

3.96M

44.18M

Minority Interest

--

--

--

--

Total Liabilities & Shareholders Equity

4.45M

3.03M

4.92M

45.80M

Total Common Shares Outstanding

36.29M

35.20M

35.20M

5.85M

Total Preferred Shares Outstanding

--

--

--

--